 |
BioWorld-Insight-2010-11-01
Financing Comes Full Circle; R&DLP Resurgence in Works?
Collaborations Between Biotechnology Companies and Government/Nonprofit Institutions: Jan. 1 - Oct. 29, 2010
No Abstract
Financing Comes Full Circle; R&DLP Resurgence in Works?
Private equity-backed royalty deals, a relatively new edition to the biotech world, have already evolved from financing vehicle to strategic portfolio management tool. Now they seem to be evolving again, this time toward earlier-stage project financing, and they're starting to look a little like one of the oldest tricks in biotech's playbook: the Research and Development Limited Partnership (R&DLP).